Clinical Trial Update: Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating safety, efficacy, and pharmacokinetics of BT-114143 Injection in patients with abnormal uterine bleeding is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding

Drugs mentioned

• BT-114143 Injection (BT-114143)

Snippet

Sponsor: ScinnoHub Pharmaceutical Co., Ltd. | Conditions: Abnormal Uterine Bleeding | Phase 1 | Status: RECRUITING